The response to antiviral therapy for chronic hepatitis C virus (HCV) is complex and is determined by both environmental and genetic factors. Recently, interacting gene polymorphisms of the chemokine RANTES have been shown to affect HIV disease progression. Our aim was to assess if these RANTES vari
Baseline cholesterol is associated with the response to antiviral therapy in chronic hepatitis C
โ Scribed by Michael Economou; Haralampos Milionis; Spyridon Filis; Gerasimos Baltayiannis; Leonidas Christou; Moses Elisaf; Epameinondas Tsianos
- Book ID
- 108951368
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 88 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0815-9319
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Hepatitis B virus (HBV) genotype and precore/core promoter mutations have been implicated in spontaneous and interferon alfa (IFN-+related hepatitis B e antigen (HBeAg) seroconversion. We performed a retrospective analysis of a previously reported randomized controlled trial to determine the effects
Differential response patterns to optimal antiviral therapy, peginterferon alpha plus ribavirin, are well documented in patients with chronic hepatitis C virus (HCV) infection. Among many factors that may affect therapeutic efficiency, HCV quasispecies (QS) characteristics have been a major focus of
The likelihood of a sustained response to a course of interferon in patients with chronic hepatitis C correlates with several clinical and viral factors, including age, viral genotype and initial levels of hepatitis C virus (HCV) RNA in serum. The role of race and ethnicity has not been assessed. We
We read with great interest the article by Martinot-Peignoux et al. 1 In this report from France, undetectable serum hepatitis C virus (HCV) RNA at 12 weeks (Wรพ12) (409 patients) post-treatment follow-up was as relevant as undetectable serum HCV RNA at 24 weeks (Wรพ24) (sustained virological response